ASAM's public policy statements guide its advocacy on legislative and regulatory issues.

Endorsed Public Policy Statement on Buprenorphine Administration in the Emergency Department

Adoption Date:
July 17, 2019



On July 17, 2019, ASAM’s Board of Directors approved ASAM’s endorsement of the American College of Medical Toxicology's position statement "Buprenorphine Administration in the Emergency Department." The policy statement acknowledges the increasing number of opioid-related emergency department (ED) visits and fatalities occurring across the nation, before endorsing the administration of buprenorphine to appropriate patients in the ED to treat opioid withdrawal and to reduce the risk of opioid overdose and death following discharge, as well as the administration of buprenorphine in the ED as a bridge to long-term addiction treatment.